| NDC Code | 58048-0005-1 |
|---|
| Package Description | 60 mL in 1 BOTTLE, DROPPER (58048-0005-1) |
|---|
| Product NDC | 58048-0005 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Lyme And Co-infection Nosode |
|---|
| Non-Proprietary Name | Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Babesia Microti, Borrelia Burgdorferi Nosode, Latrodectus Mactans, Citricum Acidum, Cytomegalovirus Nosode, Rickettsia Nosode (rickettsia Prowazekii), Chlamydia Trachomatis, Ledum Palustre |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20200317 |
|---|
| End Marketing Date | 20270919 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Bhp Holdings, Inc. |
|---|
| Substance Name | ANGELICA ARCHANGELICA ROOT; POTASSIUM CHLORIDE; YUCCA FILAMENTOSA; SUS SCROFA CARTILAGE; PHYTOLACCA AMERICANA ROOT; GOLDENSEAL; TOXICODENDRON PUBESCENS LEAF; CAUSTICUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE; OXALIC ACID; ARNICA MONTANA; BABESIA MICROTI; BORRELIA BURGDORFERI; LATRODECTUS MACTANS; ANHYDROUS CITRIC ACID; HUMAN HERPESVIRUS 5; RICKETTSIA PROWAZEKII; CHLAMYDIA TRACHOMATIS; LEDUM PALUSTRE TWIG |
|---|
| Strength | 2; 6; 8; 12; 12; 6; 12; 5; 6; 12; 30; 8; 8; 8; 4; 3; 8; 4; 6; 3 |
|---|
| Strength Unit | [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
|---|
| Pharmacy Classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
|---|